Akums Drugs and Pharmaceuticals received a voluntary ESG rating of 63 for FY 2024-25 from NSE Sustainability.
The rating was assigned based on publicly available information without company engagement.
The disclosure was made to NSE and BSE under SEBI Listing Regulations.